Collectively, these results describe that DNMTi-induced ICAM-1 upregulation correlates with a modulation of melanoma secretome in inducing the secretion of the T-cell chemokines CXCL9 and CXCL10 and with the survival positive predictor 12-chemokine melanoma signature. This evidence concerns the gene ICAM1 and melanoma.